ROCKVILLE, Md. – June 6, 2024 – The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, today published a set of evidence-based recommendations for ...

ROCKVILLE, Md. – June 24, 2025 – The Association for Molecular Pathology, the premier global molecular diagnostic professional society, today announced the publication of best practice recommendations ...

New research has shown that RNA-based testing can improve the detection and interpretation of clinically actionable genomic alterations that lead to MET exon 14 skipping in patients with lung ...

The College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) announced today the open comment ...

IVDR: where are we now in molecular testing? How IVDR implementation is progressing in molecular biology laboratories in different European countries IVDR, the new EU legislation for in-vitro ...

Molecular testing, including chromosomal microarray analysis, distinguishes between aggressive and indolent kidney cancer subtypes, aiding in accurate diagnosis. Accurate diagnosis is critical for ...

PASADENA, Calif. & RIYADH, Saudi Arabia--(BUSINESS WIRE)--OmniPathology, a U.S.-based advanced molecular diagnostics laboratory, today announced a new international collaboration with Delta Medical ...

On-site pathology tests for infectious diseases in rural and remote locations can be just as reliable and accurate as tests carried out in a hospital laboratory, a new report from Flinders University ...

With more than 150,000 new colorectal cancer cases diagnosed annually in the United States, metastatic colorectal cancer (mCRC) remains an area of significant unmet medical need.

In the era of precision oncology, research focused on evaluating molecular profiles and optimizing molecular testing in advanced NSCLC is increasingly crucial, particularly in low- and middle-income ...